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Abstract
Background: Virus infections are the major cause of asthma exacerbations. CD8+ T cells have an
important role in antiviral immune responses and animal studies suggest a role for CD8+ T cells in
the pathogenesis of virus-induced asthma exacerbations. We have previously shown that the
presence of IL-4 during stimulation increases the frequency of IL-5-positive cells and CD30 surface
staining in CD8+ T cells from healthy, normal subjects. In this study, we investigated whether excess
IL-4 during repeated TCR/CD3 stimulation of CD8+ T cells from atopic asthmatic subjects alters
the balance of type 1/type 2 cytokine production in favour of the latter.
Methods: Peripheral blood CD8+ T cells from mild atopic asthmatic subjects were stimulated in
vitro with anti-CD3 and IL-2 ± excess IL-4 and the expression of activation and adhesion molecules
and type 1 and type 2 cytokine production were assessed.
Results: Surface expression of very late antigen-4 [VLA-4] and LFA-1 was decreased and the
production of the type 2 cytokines IL-5 and IL-13 was augmented by the presence of IL-4 during
stimulation of CD8+ T cells from mild atopic asthmatics.
Conclusion: These data suggest that during a respiratory virus infection activated CD8+ T cells
from asthmatic subjects may produce excess type 2 cytokines and may contribute to asthma
exacerbation by augmenting allergic inflammation.
Background
Asthmatic airways are characterised by high levels of IL-4
due to excess Th2 responses to common aeroallergens [1-
3]. Respiratory viruses are associated with 80 to 85% of
asthma exacerbations in children and with 60% in adults
and rhinovirus (RV) is common in all age groups [4-6].
We have found that atopic asthmatic subjects suffer from
more severe and longer lasting lower respiratory tract
symptoms when infected with RV than do normal sub-
jects [7], but the mechanisms are not known. We pro-
posed that one mechanism could be that immune
responses to virus infection are type 1 deficient/type 2
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augmented if they take place in a milieu rich in the type 2
cytokine IL-4 as occurs in atopic asthma [8]. Optimal
CD8+ T cell responses to respiratory viruses are predomi-
nantly type 1 and over exuberant type 2 responses are det-
rimental [9]. Animal studies suggest that immune
responses to virus infections are characterized by an
increase in the frequency of type 2 cytokine-producing T
cells if they take place in an allergic environment [10,11].
Data from human studies also show that an excessive type
2/deficient type 1 cytokine response to RSV-infection in
the respiratory tract is associated with a more severe clini-
cal course [12].
We have published data showing that human CD8+ T cells
from both normal and asthmatic subjects have the capac-
ity to produce type 2 cytokines [13,14]. We have recently
shown that stimulation of CD8+ T cells from normal,
healthy subjects in an IL-4 rich milieu significantly
increased the number of IL-5-positive CD8+ T cells [15].
Due to excess Th2 immune response to allergens, CD8+ T
cells from atopic asthmatic subjects are continuous
exposed to IL-4 [1]. Here we investigated whether exoge-
nous IL-4 present during TCR/CD3 stimulation modu-
lates cell growth, surface phenotype (activation markers
and adhesion molecules) and type 1 (IL-2 and IFN-γ) and
type 2 (IL-4, -5, -13) cytokine production in CD8+ T cells
from atopic asthmatic subjects. We found that the pres-
ence of exogenous IL-4 during the activation of mild
atopic asthmatic CD8+ T cells enhanced cell growth and
increased IL-5 and IL-13 production.
Methods
Subjects
Peripheral blood (40 to 50 mL) was obtained from 10
patients fulfilling clinical diagnostic criteria for asthma
[16] and showing hyperreactivity to inhaled metha-
choline (Table 1). Asthmatic patients were classified as
having mild-to-moderate asthma according to the stand-
ards of American Thoracic Society [16] and were treated
with selective beta2-agonists as required. All asthmatic
patients were atopic with high levels of total serum IgE
(>80 IU/mL) and with positive skin prick test responses
(greater than 3 mm skin wheal response) to one or more
of a series of common allergens: house dust mite, mixed
grass pollens, mixed tree pollens, mixed feathers, cat fur
and dog hair (ALK, Denmark). None of the subjects were
smokers or had a history of respiratory tract infections
within the previous two months. The study was approved
by Southampton Joint University and Hospital Ethics
Committee.
Antibodies and other reagents
"CD8+ T cell isolation" kits were from Miltenyi (Miltenyi
Biotec GmbH, Germany). Mouse anti-human CD3 Abs
was purified from the OKT-3 hybridoma (American Type
Culture Collection, Rockville, USA). rIL-2 and rIL-4 were
purchased from Genzyme (Genzyme, West Malling, Kent,
UK). Leu 4 (CD3)-Peridinin Chlorophyll Protein conju-
gate, Leu 3a (CD4)-FITC and -phycoerythrin (PE), Leu 2a
(CD8)-FITC and -PE, CD14-PE, CD16-PE, CD19-PE,
CD25-FITC, CD11a (LFA-1)-FITC and CD49d (VLA-4)-PE
were from Becton Dickinson (Becton Dickinson, Moun-
tain View, CA). CD54 (ICAM-1)-FITC was from Serotec
(Serotec Ltd, Oxford, UK). CD30-FITC and CD154 (CD40
ligand, CD40L)-PE were from PharMingen (PharMingen,
San Diego, CA). ELISA kits were obtained from Biosource
(Biosource Europe S.A., Fleurus, Belgium).
CD8+ T cell purification and culture
CD8+ T cells were enriched by negative immunomagnetic
selection using the MACS system [17]. After passage
through MACS columns, between 0.25 and 2.3 × 106
CD8+ T cells were recovered from 1 mL of blood. The
resulting cell populations were routinely >98% CD3+ and
>97% CD8+ and contained no detectable CD4+, CD16+,
CD19+, CD14+ cells as determined by flow cytometry.
Purified CD8+ T cells were cultured in an antigen present-
ing cell-free system as previously described [15]. In brief,
0.5 × 106 cells/mL were stimulated for 3 days with plate-
bound anti-CD3 Abs (10 µg/mL) in 96-well microtiter
plates in RPMI 1640 culture medium supplemented with
10% FCS, 2 mM L-glutamine, 1 mM sodium pyruvate,
antibiotics (all from Gibco BRL, Life Technologies,
Uxbridge, UK), IL-2 (50 U/mL) with or without added IL-
4 (10 ng/mL) (stimulation). After 3 days, the cells were
Growth kinetics (fold increase) of CD8+ T cell numbers Figure 1
Growth kinetics (fold increase) of CD8+ T cell 
numbers. Data are means ± SEM (n = 10 subjects). * p < 
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harvested, washed, adjusted to 0.2 × 106/mL and cultured
for 4 days in culture medium containing IL-2 (50 U/mL)
(expansion). After every cycle of stimulation or expansion
the cells were harvested and the number of live cells was
determined by trypan blue exclusion and counting. After
the second cycle of stimulation and expansion the cells
were harvested, washed, adjusted to 1 × 106/mL and
analysed.
Cell surface markers
Following the second cycle of stimulation/expansion, the
cells were harvested and washed. PerCP-, FITC-, and PE-
conjugated antibodies were added to 50 µl of suspensions
(0.05 × 106 cells) and incubated for 30 min at 4°C. After
washing in PBS, stained cells were resuspended in 500 µl
PBS. Flow cytometry was performed on a FACScan (Bec-
ton Dickinson, San Jose, CA). The FACScan program was
used to acquire data of 10,000 events and the data were
analysed by using Lysys II software. Live lymphocytes
were gated by the forward scatter and side scatter pattern.
Percentage in dot plots and mean fluorescence intensity
(MFI) in histograms were analysed on CD3+CD8+ cells for
the molecules of interest.
Cytokine production
After two cycles of stimulation/expansion, CD8+ T cells (1
× 106/mL) were restimulated for 24 hours with phorbol
myristate acetate (PMA) (20 ng/mL) and ionomycin (2
µg/mL) or with immobilised anti-CD3 Ab. Supernatants
were microfuged for 5 minutes at 400 g to remove cell
debris and IL-2, IL-4, IL-5, IL-13, and IFN-γ levels were
measured by ELISA using commercial assay kits (Bio-
source, Europe SA). The limits of sensitivity of these assays
were 3 pg/mL for IL-4, 4 pg/mL for IL-5 and IFN-γ, 5 pg/
mL for IL-2, and 12 pg/mL for IL-13.
Statistical analysis
Paired Student t-test was used to analyse normally distrib-
uted data such as growth of CD8+ T cells cultured with or
without IL-4. The Wilcoxon signed rank test for paired
data was used for comparison of surface markers and for
cytokine levels in culture supernatants. P values less than
0.05 were chosen for rejection of the null hypothesis.
Results
IL-4 amplifies the growth of CD8+ T cells from atopic 
asthmatic subjects
In order to analyse the effect of IL-4 on CD8+ T cell growth
we examined cell recovery after the first and second cycles
of stimulation and expansion. At the end of the first cycle
of stimulation/expansion there was no difference in the
number of CD8+ T cells cultured with or without IL-4
(data not shown), but after the second cycle the number
of cells stimulated in the presence of IL-4 was significantly
higher than number of cells stimulated in the absence of
IL-4 (4.5 ± 0.7 fold increase relative to the initial popula-
tion in the presence of exogenous IL-4 versus 2.9 ± 0.7
fold increase without exogenous IL-4 (Fig. 1, P < 0.02).
IL-4 decreases surface expression of adhesion molecules in 
CD8+ T cells from atopic asthmatic subjects
As we were interested in airway responses of CD8+ T in the
context of viral infection, we then investigated whether
levels of expression of surface antigens associated with
activation, adhesion and transmigration capabilities were
altered by the presence of IL-4 during CD8+ T cell stimula-
tion (Table 2). There was a trend to increased numbers of
CD30-positive CD8+ T cells in culture with exogenous IL-
4 but the difference did not reach significance (P < 0.07).
However, the presence of exogenous IL-4 during stimula-
Table 1: Characteristics of subjects
Asthma subjects (n = 10)
Age (years)
Mean (Range) 33 (20–48)
Sex (male/female) 5/5
PC20 methacholine (mg/mL) *
Geometric mean (range) 5.33 (1.5 to 7.9)
Atopy# 10
Serum IgE (IU/mL)
Median (range) 100 (81 to 442)
*Provocative concentration of methacholine required to cause a 20% 
decrease in baseline forced expiratory volume in 1 second (FEV1).
# Positive skin reactivity to a panel of common allergen (see methods)
Table 2: Surface molecules on repeatedly stimulated CD8+ T 
cells*
IL-4 - + P†
CD3+ 97 ± 1 98 ± 0.5 NS
CD3+CD8+CD4- 97 ± 1 97 ± 1 NS
CD3+CD4+CD8- 0.2 ± 0.2 0.3 ± 0.2 NS
CD3+CD4-CD8- 2 ± 1 2 ± 1 NS
CD3+CD4+CD8+ 7 ± 6 4 ± 1 NS
CD3+CD8+
CD25 53 ± 9 68 ± 9 NS
CD30 23 ± 7 40 ± 6 0.07
CD40L 14.5 ± 5 14.5 ± 6 NS
VLA-4# 444 ± 97 283 ± 72 0.02
LFA-1# 280 ± 51 194 ± 25 0.05
ICAM-1# 37 ± 10 27 ± 7 0.06
*frequency of positive cells or #mean fluorescence intensity of surface 
antigens after two rounds of stimulation of CD8+ T cells from atopic 
asthmatic subjects (mean ± SEM; n = 7; NS, nonsignificant).
† comparison between IL-4-treated and -untreated cells (paired 
Student's t test)Respiratory Research 2005, 6:67 http://respiratory-research.com/content/6/1/67
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tion induced a significant decrease in the expression
(assessed by MFI) on CD8+ T cells of the adhesion mole-
cules VLA-4 (CD29/CD49d) (P < 0.02) and LFA-1 (P <
0.05). There was a trend towards a similar reduction in
ICAM-1 expression, though this did not reach statistical
significance (P < 0.06).
IL-4 enhances type 2 cytokine production by CD8+ T cells 
from atopic asthmatic subjects
To investigate whether the presence of IL-4 during CD8+ T
cell stimulation alters the cytokine production pattern,
CD8+ T cells harvested after two cycles of stimulation/
expansion were restimulated with PMA/ionomycin or
immobilized anti-CD3 Abs for 24 h to investigate
cytokine synthesis and release into supenatants. The pat-
terns of alteration in cytokine secretion following 24 h res-
timulation with anti-CD3 Abs (data not shown) were
similar to that observed after PMA and ionomycin restim-
ulation (Fig. 2).
Type 2 cytokine production by repeatedly stimulated
CD8+ T cells from atopic asthmatic subjects was increased
by the presence of IL-4 during stimulation (Fig. 2). There
was a trend towards an increase in IL-4 (median and
[range]) production by CD8+ T cells stimulated in the
presence of IL-4 (without IL-4, 146 pg/mL [20 to 793 pg/
mL]; with IL-4, 389 pg/mL [45 to 4309 pg/mL], P < 0.1).
IL-5 levels were significantly increased by the presence of
IL-4 (without IL-4, 494 pg/mL [56 to 1612 pg/mL]; with
IL-4, 1251 pg/mL [391 to 10936 pg/mL], P < 0.02). IL-13
levels were also significantly increased by the presence of
IL-4 during CD8+ T cell stimulation (without IL-4, 1045
pg/mL [378 to 1392 pg/mL]; with IL-4, 1455 pg/mL [580
to 5820 pg/mL], P < 0.01).
Excess IL-4 during repeated stimulation of CD8+ T cells
did not significantly alter the levels of IL-2 (without IL-4,
2000 pg/mL [1000 to 4000 pg/mL]; with IL-4, 2135 pg/
mL [1000 to 2900 pg/mL]) and IFN-γ (without IL-4, 22
ng/mL [2 to 44 ng/mL]; with IL-4, 23 ng/mL [1 to 44 ng/
mL] released in culture by CD8+ T cells.
Discussion
In this study, we show that excess exogenous IL-4 during
in vitro CD8+ T cell stimulation amplified the proliferation
of CD8+ T cells from atopic asthmatic subjects. Further-
more, excess IL-4 resulted in a decrease in the expression
of the adhesion molecules VLA-4 and LFA-1 on CD8+ T
cells, along with increased production of the type 2
cytokines IL-5 and IL-13. These data indicate that the acti-
vation of CD8+ T cells from asthmatic subjects in the pres-
ence of IL-4 increases their capacity to produce type 2
cytokines but not IFN-γ or IL-2. These effects may be
important in promoting adverse CD8+ T cell responses to
virus infections in asthmatic subjects.
The presence of exogenous IL-4 during TCR/CD3 stimula-
tion of peripheral blood CD8+ T cells induced expansion
of cell numbers. It has previously been reported that IL-4
may act as a growth factor for human CD4+ and CD8+ T
cell clones and that there is a synergy between IL-2 and IL-
4 during CD8+ T cell proliferation [18]. This suggests that
stimulation of CD8+ T cells in an environment rich in IL-
4 may result in the expansion of CD8+ T cells when exog-
enous IL-2 is present.
CD8+ T cells exposed to repeated stimulation in the pres-
ence of exogenous IL-4 decreased their expression of the
α4β1 integrin (VLA-4, CD49d/CD29) and αLβ2 integrin
(LFA-1, CD11a/CD18). VLA-4 is a surface marker associ-
ated with the capacity of T cells to migrate towards sites of
antigen stimulation [19] and it has been previously
reported that CD49d membrane expression on Th1 and
Th2 clones is markedly reduced by activation [20]. The
reduction in the levels of adhesion molecules as a result of
activation of CD8+ T cells may play a role in the retention
of activated cells at sites of antigenic stimulation.
Recently, in an animal model it was reported that type 2
or type 0 CD8+ T cells had decreased surface VLA-4 density
and deficient activation-induced LFA-1/ICAM-1-depend-
ent homotypic adhesion in vitro and consequently
reduced antiviral activity in vivo [21]. The presence of
exogenous IL-4 during stimulation of CD8+ T cells also
tended to increase the frequencies of CD30-positive cells.
The expression of CD30, a member of the TNF receptor
family, by T cells has been previously reported to be pri-
marily regulated by IL-4 [22] and preferentially expressed
by type 2 and type 0 cells [20]. These data collectively sug-
gest that the presence of IL-4 in the microenvironment
induces a phenotype of cells similar to tissue-resident cells
and induces patterns of expression of adhesion molecules
associated with adoption of type 2 function. These data
suggest our in vitro observations on induction of type 2
functions more likely to truly reflect events occurring in
the lungs in vivo.
We have found that peripheral blood CD8+ T cells from
atopic asthmatic individuals, when stimulated in the pres-
ence of exogenous IL-4, released higher levels of IL-5 and
IL-13 as compared with CD8+ T cells stimulated in the
absence of IL-4. It has previously been reported that exog-
enous IL-4 increased production of IL-4 and IL-5 in stim-
ulated neonatal CD8+ T cells [23]. However, it is now
known that neonatal T cells are skewed towards a type 2
phenotype and may, therefore, not be representative of
adult human CD8+ T cells [24]. We have recently reported
induction of type 2 activities in CD8+ T cells from healthy
adult subjects during TCR stimulation by the presence of
exogenous IL-4 [15]. However, we observed only a ten-
dency to increased IL-5-production and no increased IL-
13-production in CD8+ T cells from normal subjects [[15]Respiratory Research 2005, 6:67 http://respiratory-research.com/content/6/1/67
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Exogenous IL-4 during TCR/CD3 stimulation increased type 2 cytokine production in culture supernatants of CD8+ T cells  from atopic asthmatic subjects Figure 2
Exogenous IL-4 during TCR/CD3 stimulation increased type 2 cytokine production in culture supernatants of 
CD8+ T cells from atopic asthmatic subjects. CD8+ T cells were stimulated with anti-CD3 Abs+IL-2 in the presence or 
absence of IL-4 for 3 days followed by 4 days expansion with IL-2 alone- this cycle of stimulation/expansion was then repeated. 
Cells were then harvested and restimulated (1 × 106/mL) with PMA and ionomycin. Supernatants were collected after 24 
hours, and cytokines measured by ELISA. Cytokine data are median (quartiles 75) of 10 atopic asthmatic subjects. * p < 0.05
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and unpublished data]. In the present study we extend
these findings to confirm that induction by IL-4 of type 2
activities also occurs in CD8+ T cells from asthmatic sub-
jects and demonstrate the deviation in phenotype towards
type 2 is more extensive with increases in IL-5 and IL-13
production.
Respiratory virus infections are frequently associated with
asthma exacerbations and CD8+ T cells are important in
anti-viral immune responses. Given the above data in our
in vitro model, we suggest that stimulation of CD8+ T cells
during viral infections in an environment enriched in IL-
4 as occurs in asthma is likely to favour the induction of
type 2 cytokine synthesis by CD8+ T cells. Production of
type 2 cytokines by CD8+  T cells during immune
responses to viral infections in asthma has the potential to
augment allergic inflammation by a number of different
mechanisms including each of the type 2 cytokines meas-
ured in this study. This hypothesis is lent credence by our
recent observations that virus infection and allergen expo-
sure are synergistic risk factors for acute exacerbations of
asthma [25].
By antagonising the production of IFN-γ, type 2 cytokines
may also have effects on the capacity of CD8+ T cells to
clear virus. In our culture conditions, even though exoge-
nous IL-4 did not significantly decrease the levels of IFN-
γ, the levels remained stable and the ratio of IL-4/IFN-γ
was increased (data not shown). It is quite possible that
during respiratory viral infections in asthmatic relative to
normal subjects in vivo, where the stimulation conditions
are different, IFN-γ production is depressed as a result of
these mechanisms. This hypothesis is supported by the
observation in mice that elevation of IL-4 levels concur-
rent with viral infections suppresses or delays activation of
virus-specific CD8+ T cells and leads to delayed viral clear-
ance [26-28]. We have previously reported a significant
increase in submucosal CD4+ and CD8+ lymphocytes and
in epithelial eosinophils in both normal and asthmatic
subjects with experimental rhinovirus infections, and in
asthmatic subjects eosinophil numbers remained elevated
during convalescence [29]. These data suggest that modu-
lation by IL-4 of CD8+ virus-specific immune responses
towards a type 2 phenotype may occur in humans in vivo,
and that this may be an important mechanism in virus-
induced exacerbations of asthma acting both by augment-
ing allergic inflammation and by diminishing viral clear-
ance. A recent rhinovirus experimental infection study has
supported this hypothesis by observing impaired virus
clearance and increased symptoms in subjects with
increased IL-5/IFN-γ mRNA ratios in induced sputum
[30].
Conclusion
In conclusion, our data demonstrate induction of type 2
cytokine production and a tissue-resident phenotype by
exogenous IL-4 in CD8+ T cells from atopic asthmatic sub-
jects. Given the excess IL-4 observed in asthma we believe
that these mechanisms may play an important role in
impairing virus clearance and augmenting allergic inflam-
mation in virus-induced asthma. We are currently testing
this possibility in vivo in human experimental virus infec-
tion models.
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